Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential.
暂无分享,去创建一个
Vivek Agrahari | Vibhuti Agrahari | Pierre-Alain Burnouf | Thierry Burnouf | V. Agrahari | Vibhuti Agrahari | Pierre-Alain Burnouf | T. Burnouf | Vivek Agrahari | Vibhuti Agrahari
[1] S. Mitragotri,et al. Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[2] V. Jain,et al. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. , 2015, Current drug delivery.
[3] T. Iwamoto. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. , 2013, Biological & pharmaceutical bulletin.
[4] C. Fan,et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. , 2011, ACS nano.
[5] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[6] J. Feijen,et al. Highly efficacious and specific anti‐glioma chemotherapy by tandem nanomicelles co‐functionalized with brain tumor‐targeting and cell‐penetrating peptides , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[7] Alexander V Kabanov,et al. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. , 2017, Biomaterials.
[8] Markus Schulz,et al. Fetal Bovine Serum (FBS): Past - Present - Future. , 2018, ALTEX.
[9] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[10] Thomas J Webster,et al. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity , 2014, International journal of nanomedicine.
[11] A. Fonteh,et al. Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges , 2005, Disease markers.
[12] Caterina Minelli,et al. A comparison of techniques for size measurement of nanoparticles in cell culture medium , 2016 .
[13] P. Davy,et al. Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue – Evaluations on Monocyte-Based Delivery System for the Central Nervous System , 2016, PloS one.
[14] J. Kreuter,et al. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.
[15] C. Solans,et al. Characterization of Polymeric Nanoparticle Dispersions for Biomedical Applications: Size, Surface Charge and Stability. , 2018, Pharmaceutical nanotechnology.
[16] Elisabetta Muntoni,et al. Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery , 2018, Expert opinion on drug delivery.
[17] T. Yonezawa,et al. Synovial fluid total protein concentration as a possible marker for canine idiopathic polyarthritis , 2015, The Journal of veterinary medical science.
[18] G. Sancini,et al. Artificial apolipoprotein corona enables nanoparticle brain targeting. , 2018, Nanomedicine : nanotechnology, biology, and medicine.
[19] Jing Zhao,et al. Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona , 2018, Nature Communications.
[20] F. Schacher,et al. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. , 2016, The international journal of biochemistry & cell biology.
[21] A. Mitra,et al. Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches , 2017, Expert opinion on drug delivery.
[22] Paul R. Lockman,et al. Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.
[23] Ronald J Moore,et al. Characterization of the human blood plasma proteome , 2005, Proteomics.
[24] Mayur M. Patel,et al. Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain , 2017, CNS Drugs.
[25] Gerhard Gstraunthaler,et al. Zell- und Gewebekultur , 2013 .
[26] Sun Young Min,et al. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[27] Qing Yao,et al. Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types , 2018, Front. Pharmacol..
[28] Zhiyuan Hu,et al. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns. , 2017, Colloids and surfaces. B, Biointerfaces.
[29] T. Snoeks,et al. Effect of PLGA NP size on efficiency to target traumatic brain injury. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[30] Sarika Wairkar,et al. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. , 2018, International journal of biological macromolecules.
[31] P. Altevogt,et al. Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.
[32] E. MetwalliNabila. WHO RECOMMENDATIONS FOR THE PRODUCTION, CONTROL AND REGULATION OF HUMAN PLASMA FOR FRACTIONATION , 2011 .
[33] Samir Mitragotri,et al. Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude , 2018, Nature Communications.
[34] Nathan McDannold,et al. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. , 2014, Advanced drug delivery reviews.
[35] E. Diamandis,et al. Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery , 2017, Critical reviews in clinical laboratory sciences.
[36] Erno Pungor,et al. Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs , 2008, Biotechnology progress.
[37] Tushar Patel,et al. Circulating Extracellular Vesicles in Human Disease. , 2018, The New England journal of medicine.
[38] P. Zahedi,et al. Recent advances in drug delivery strategies for treatment of ovarian cancer , 2012, Expert opinion on drug delivery.
[39] Raimo Hartmann,et al. Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles. , 2015, Angewandte Chemie.
[40] N. Abbott. Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.
[41] S. Mitragotri,et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. , 2015, ACS nano.
[42] A. Doucet-Panaye,et al. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches , 2016, SAR and QSAR in environmental research.
[43] Pablo Játiva,et al. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. , 2018, Nanomedicine.
[44] D. Weitz,et al. Interaction of spin-labeled HPMA-based nanoparticles with human blood plasma proteins - the introduction of protein-corona-free polymer nanomedicine. , 2018, Nanoscale.
[45] Kevin Braeckmans,et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. , 2013, ACS nano.
[46] Peter Kearns,et al. Physico-chemical properties of manufactured nanomaterials - Characterisation and relevant methods. An outlook based on the OECD Testing Programme , 2018, Regulatory toxicology and pharmacology : RTP.
[47] P. Botella,et al. Protein Adsorption From Biofluids on Silica Nanoparticles: Corona Analysis as a Function of Particle Diameter and Porosity. , 2015, ACS applied materials & interfaces.
[48] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[49] N. Baldini,et al. Exosomes: novel effectors of human platelet lysate activity. , 2014, European cells & materials.
[50] Jing Qin,et al. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma , 2016, Oncotarget.
[51] Vivek Agrahari,et al. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. , 2018, Drug discovery today.
[52] S. Benita,et al. Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study , 2006, Journal of drug targeting.
[53] María José Marchant,et al. Metal Nanoparticles for the Treatment and Diagnosis of Neurodegenerative Brain Diseases. , 2017, Current pharmaceutical design.
[54] T. Ishida,et al. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[55] Ping-Chang Lin,et al. Techniques for physicochemical characterization of nanomaterials. , 2014, Biotechnology advances.
[56] A. Jones,et al. Nanoparticle geometry and surface orientation influence mode of cellular uptake. , 2013, ACS nano.
[57] W. Robberecht,et al. Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery , 2014, Expert opinion on investigational drugs.
[58] U. Schlötzer-Schrehardt,et al. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[59] A. Silva,et al. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization , 2018, Journal of Nanobiotechnology.
[60] J. Tsibouklis,et al. Nano carriers for drug transport across the blood–brain barrier , 2017, Journal of drug targeting.
[61] M. Mahmoudi,et al. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.
[62] D. Van Roost,et al. The influence of cerebrospinal fluid on blood coagulation and the implications for ventriculovenous shunting. , 2019, Journal of neurosurgery.
[63] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[64] Jinchao Zhang,et al. Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer's Disease Therapy , 2016, Advanced materials.
[65] S. Krol,et al. Protein corona: implications for nanoparticle interactions with pulmonary cells , 2017, Particle and Fibre Toxicology.
[66] S. Tamilvanan,et al. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of ibuprofen , 2006, AAPS PharmSciTech.
[67] Raquel Ferreira,et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[68] X. Cui,et al. ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood–brain barrier , 2018, Journal of Nanobiotechnology.
[69] Nobuhiro Nishiyama,et al. Nanomedicine: nanocarriers shape up for long life. , 2007, Nature nanotechnology.
[70] Jennifer I. Hare,et al. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.
[71] Samir Mitragotri,et al. Physical approaches to biomaterial design. , 2009, Nature materials.
[72] Cheng Dong,et al. Design strategies and applications of circulating cell-mediated drug delivery systems. , 2015, ACS biomaterials science & engineering.
[73] Roger M. Leblanc,et al. Crossing the blood‐brain barrier with nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[74] Quanyin Hu,et al. Dual targeted nanocarrier for brain ischemic stroke treatment. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[75] V. Ceña,et al. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. , 2016, Nanomedicine.
[76] Peter J Millett,et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis , 2007, Arthritis research & therapy.
[77] D. Devos,et al. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment , 2015, Transfusion.
[78] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[79] Farooq Ali Khan,et al. Nanoemulsion: Concepts, development and applications in drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[80] Nguyen T. K. Thanh,et al. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. , 2018, Nanoscale.
[81] R. Schiffelers,et al. Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.
[82] C R Merril,et al. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. , 1980, Clinical chemistry.
[83] Yong Song Gho,et al. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum , 2014, Journal of extracellular vesicles.
[84] C. Teunissen,et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. , 2014, Journal of proteomics.
[85] W. Pardridge. Molecular Trojan horses for blood-brain barrier drug delivery. , 2006, Discovery medicine.
[86] Ching-Li Tseng,et al. Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products , 2018, Front. Med..
[87] Kaoxiang Sun,et al. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease , 2018, International journal of nanomedicine.
[88] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[89] Elizabeth Nance,et al. A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.
[90] Venkatareddy Nadithe,et al. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.
[91] Warren C W Chan,et al. Effect of gold nanoparticle aggregation on cell uptake and toxicity. , 2011, ACS nano.
[92] J. Kaplan,et al. Platelet removal from the circulation by the liver and spleen. , 1978, The American journal of physiology.
[93] J. Dernouchamps. The proteins of the aqueous humour , 1982, Documenta Ophthalmologica.
[94] Ying Fan,et al. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases. , 2018, Critical reviews in therapeutic drug carrier systems.
[95] Otto L Muskens,et al. Interactions of human endothelial cells with gold nanoparticles of different morphologies. , 2012, Small.
[96] S. Hamann,et al. Osmolality of Cerebrospinal Fluid from Patients with Idiopathic Intracranial Hypertension (IIH) , 2016, PloS one.
[97] H. Sheardown,et al. Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology. , 2007, The ocular surface.
[98] Meg Duroux,et al. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.
[99] Thierry Burnouf,et al. Extracellular Microvesicles as New Industrial Therapeutic Frontiers. , 2019, Trends in biotechnology.
[100] Nitish Thakor,et al. Biocompatible Red Fluorescent Organic Nanoparticles with Tunable Size and Aggregation‐Induced Emission for Evaluation of Blood–Brain Barrier Damage , 2016, Advanced materials.
[101] Philip Demokritou,et al. High Resolution Characterization of Engineered Nanomaterial Dispersions in Complex Media Using Tunable Resistive Pulse Sensing Technology , 2014, ACS nano.
[102] Zhi Zhu,et al. In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. , 2014, ACS applied materials & interfaces.
[103] Diego Stéfani T. Martinez,et al. Silver nanoparticle protein corona and toxicity: a mini-review , 2015, Journal of Nanobiotechnology.
[104] S. Rome,et al. Depleting extracellular vesicles from fetal bovine serum alters proliferation and differentiation of skeletal muscle cells in vitro , 2016, BMC Biotechnology.
[105] Ravish J. Patel,et al. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies. , 2016, Current Drug Delivery.
[106] M. Wiesner,et al. Characterization of surface hydrophobicity of engineered nanoparticles. , 2012, Journal of hazardous materials.
[107] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[108] Iseult Lynch,et al. Serum heat inactivation affects protein corona composition and nanoparticle uptake. , 2010, Biomaterials.
[109] Huile Gao,et al. Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona. , 2018, ACS applied materials & interfaces.
[110] R. Haag,et al. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties. , 2017, Biomacromolecules.
[111] C. Svendsen,et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. , 2005, Human gene therapy.
[112] Jau-Song Yu,et al. Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. , 2011, Analytical biochemistry.
[113] A. Gürel,et al. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome , 2008, Eye.
[114] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[115] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[116] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[117] S. Kim,et al. Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II , 2018, Glycoconjugate Journal.
[118] D. Strunk,et al. International Forum on GMP‐grade human platelet lysate for cell propagation , 2018, Vox sanguinis.
[119] K. Tsubota,et al. Serum Application for the Treatment of Ocular Surface Disorders , 2000, International ophthalmology clinics.
[120] V. Mishra,et al. Dendrimer-mediated approaches for the treatment of brain tumor , 2016, Journal of biomaterials science. Polymer edition.
[121] G. Ugolini,et al. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. , 2009, Journal of Alzheimer's disease : JAD.
[122] Vivek Agrahari,et al. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology , 2016, Journal of Neuroimmune Pharmacology.
[123] S. Madi,et al. Superparamagnetic nanoparticle‐enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization , 2017, Journal of magnetic resonance imaging : JMRI.
[124] Manfred Westphal,et al. Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration. , 2017, Pediatric neurology.
[125] Caterina Minelli,et al. Size and ζ-Potential Measurement of Silica Nanoparticles in Serum Using Tunable Resistive Pulse Sensing. , 2016, Langmuir : the ACS journal of surfaces and colloids.
[126] Jungwon Yoon,et al. Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer's disease. , 2017, Nanoscale.
[127] W. Baumgartner,et al. Generation‐6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[128] Yun Hou,et al. Gene Therapy of Multiple Sclerosis Using Interferon β-Secreting Human Bone Marrow Mesenchymal Stem Cells , 2013, BioMed research international.
[129] A. Milani,et al. Crucial role of the protein corona for the specific targeting of nanoparticles. , 2015, Nanomedicine.
[130] Berislav V. Zlokovic,et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.
[131] Kenneth A. Dawson,et al. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.
[132] V. Vlassov,et al. [Characteristics of exosomes andmicroparticles discovered in human tears]. , 2016, Biomeditsinskaia khimiia.
[133] Kinam Park,et al. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. , 2013, International journal of pharmaceutics.
[134] Wolfgang J. Parak,et al. Protein corona formation around nanoparticles – from the past to the future , 2014 .
[135] Mengsu Yang,et al. Efficient RNA drug delivery using red blood cell extracellular vesicles , 2018, Nature Communications.
[136] Shantikumar V. Nair,et al. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma , 2017, Scientific Reports.
[137] Nir Lipsman,et al. Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound , 2018, Nature Communications.
[138] B. Damato,et al. Proteomic Analyses of the Vitreous Humour , 2012, Mediators of inflammation.
[139] D. Strunk,et al. International Forum on GMP‐grade human platelet lysate for cell propagation: summary , 2018, Vox sanguinis.
[140] Roberto Cingolani,et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.
[141] Pascal Richette,et al. Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents , 2012, Expert opinion on drug delivery.
[142] Peijun Wang,et al. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease. , 2018, Archives of medical research.
[143] T. Hadjistilianou,et al. Analysis of aqueous humour proteins in patients with retinoblastoma , 2012, Clinical & experimental ophthalmology.
[144] Richa Gupta,et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[145] Mojca Pavlin,et al. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona , 2017, PloS one.
[146] Sankar Basu,et al. Inner-View of Nanomaterial Incited Protein Conformational Changes: Insights into Designable Interaction , 2018, Research.
[147] Warren C W Chan,et al. Nanoparticle-blood interactions: the implications on solid tumour targeting. , 2015, Chemical communications.
[148] Y. Tabata,et al. Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[149] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[150] Jörg Huwyler,et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[151] Mark E. Davis,et al. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core , 2015, Proceedings of the National Academy of Sciences.
[152] Liang Jiang,et al. Study on the interaction of graphene oxide‑silver nanocomposites with bovine serum albumin and the formation of nanoparticle-protein corona. , 2018, International journal of biological macromolecules.
[153] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[154] A. Cianciulli,et al. Microglia‐derived extracellular vesicles in Alzheimer's Disease: A double‐edged sword , 2018, Biochemical pharmacology.
[155] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[156] Candace C. Fleischer,et al. Nanoparticle–Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes , 2014, Accounts of chemical research.
[157] M. Nasr. Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery , 2016, Drug delivery.
[158] M. M. Lunzer,et al. Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice. , 2017, ACS chemical neuroscience.
[159] Jessica M. Rosenholm,et al. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier , 2016, PloS one.
[160] Huw D. Summers,et al. Quantitative characterization of nanoparticle agglomeration within biological media , 2012, Journal of Nanoparticle Research.
[161] Mark E. Davis,et al. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor , 2013, Proceedings of the National Academy of Sciences.
[162] R. Müller,et al. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. , 2000, International journal of pharmaceutics.
[163] Nicolas Bertrand,et al. Anti‐polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[164] P. Schurtenberger,et al. Characterizing nanoparticles in complex biological media and physiological fluids with depolarized dynamic light scattering. , 2015, Nanoscale.
[165] Yaping Li,et al. Treatment of Malignant Brain Tumor by Tumor‐Triggered Programmed Wormlike Micelles with Precise Targeting and Deep Penetration , 2016 .
[166] Kenneth W. Witwer,et al. Extracellular vesicle–depleted fetal bovine and human sera have reduced capacity to support cell growth , 2015, Journal of extracellular vesicles.
[167] Kenneth J. Shea,et al. Tuning the Protein Corona of Hydrogel Nanoparticles: The Synthesis of Abiotic Protein and Peptide Affinity Reagents. , 2016, Accounts of chemical research.
[168] H. Luhmann,et al. Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates , 2018, Advanced science.
[169] K. Landfester,et al. Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.
[170] Huile Gao,et al. Progress and perspectives on targeting nanoparticles for brain drug delivery , 2016, Acta pharmaceutica Sinica. B.
[171] D. Dexter,et al. L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[172] M. Moses,et al. Nanoparticle elasticity directs tumor uptake , 2018, Nature Communications.
[173] G. Wang,et al. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[174] Pia Siljander,et al. Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum , 2018, Journal of extracellular vesicles.
[175] S. Baboota,et al. Ligand conjugation: An emerging platform for enhanced brain drug delivery , 2018, Brain Research Bulletin.
[176] Ashutosh Chilkoti,et al. Co‐opting biology to deliver drugs , 2014, Biotechnology and bioengineering.
[177] James P K Armstrong,et al. Strategic design of extracellular vesicle drug delivery systems. , 2018, Advanced drug delivery reviews.
[178] Lu Wen,et al. Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[179] The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. , 2011, Biomaterials.
[180] Jian-Qing Gao,et al. Exosomes as novel bio-carriers for gene and drug delivery. , 2017, International journal of pharmaceutics.
[181] B. Zhang,et al. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. , 2013, Biomaterials.
[182] Samir Mitragotri,et al. Non-affinity factors modulating vascular targeting of nano- and microcarriers. , 2016, Advanced drug delivery reviews.
[183] Peng Zhang,et al. Insight into the preformed albumin corona on in vitro and in vivo performances of albumin-selective nanoparticles , 2018, Asian journal of pharmaceutical sciences.
[184] Ronnie H. Fang,et al. A facile approach to functionalizing cell membrane‐coated nanoparticles with neurotoxin‐derived peptide for brain‐targeted drug delivery , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[185] F. Ahmad,et al. CNS drug delivery systems: novel approaches. , 2009, Recent patents on drug delivery & formulation.
[186] Pieter Vader,et al. Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[187] Luis M Liz-Marzán,et al. In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape. , 2018, Nanoscale.
[188] Yi-xiao Luo,et al. Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[189] Yang Yang,et al. Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma , 2017, Drug delivery.
[190] Michael A. Briggs,et al. Nanofiber-based delivery of therapeutic peptides to the brain. , 2013, ACS nano.
[191] P. Tran,et al. Modulation of serum albumin protein corona for exploring cellular behaviors of fattigation-platform nanoparticles. , 2018, Colloids and surfaces. B, Biointerfaces.
[192] Ling Zhang,et al. Dopamine‐loaded blood exosomes targeted to brain for better treatment of Parkinson's disease , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[193] Kaj Blennow,et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients , 2002, Neuroreport.
[194] Nunzio Iraci,et al. Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles , 2016, International journal of molecular sciences.
[195] J. Sousa,et al. Modeling of ultra‐small lipid nanoparticle surface charge for targeting glioblastoma , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[196] Lihong Liu,et al. Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.
[197] Mary E Napier,et al. The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[198] Shu Zhang,et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. , 2013, Biomaterials.
[199] Patrícia M. Carvalho,et al. Application of Light Scattering Techniques to Nanoparticle Characterization and Development , 2018, Front. Chem..
[200] A. Banerjee,et al. Dual functionalized liposome‐mediated gene delivery across triple co‐culture blood brain barrier model and specific in vivo neuronal transfection , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[201] S. Botchway,et al. Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics , 2018, ChemNanoMat : chemistry of nanomaterials for energy, biology and more.
[202] Tianzhi Yang,et al. Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio , 2014, Pharmaceutical Research.
[203] Svetlana Gelperina,et al. Transport of drugs across the blood-brain barrier by nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[204] I. Zuhorn,et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.
[205] W. Grizzle,et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.
[206] Chi Zhang,et al. A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment. , 2018, Current pharmaceutical biotechnology.
[207] Y. Yeo,et al. Controlled Drug Release from Pharmaceutical Nanocarriers. , 2015, Chemical engineering science.
[208] J. Lellouche,et al. The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model , 2015, Journal of Nanobiotechnology.
[209] Seyed Moein Moghimi,et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. , 2017, Nature nanotechnology.
[210] F. Rossi,et al. Characterisation of nanomaterial hydrophobicity using engineered surfaces , 2017, Journal of Nanoparticle Research.
[211] O. Eniola-Adefeso,et al. Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow. , 2017, Acta biomaterialia.
[212] J. Guan,et al. Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption , 2018, Nature Communications.
[213] S. Álvarez,et al. In vivo delivery of siRNA to the brain by carbosilane dendrimer. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[214] F. Danhier,et al. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[215] Christine Dufès,et al. Applications of dendrimers for brain delivery and cancer therapy. , 2014, Nanomedicine.
[216] V. Puntes,et al. Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona. , 2017, Bioconjugate chemistry.
[217] D. Devos,et al. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. , 2014, Blood reviews.
[218] Limin Mu,et al. Development of functional docetaxel nanomicelles for treatment of brain glioma , 2018, Artificial cells, nanomedicine, and biotechnology.
[219] Wenbo Zhan,et al. Convection enhanced delivery of chemotherapeutic drugs into brain tumour , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[220] S. Retterer,et al. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. , 2013, Nanoscale.
[221] B. Pickard,et al. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[222] Sandor Balog,et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. , 2015, Chemical Society reviews.
[223] E. Tasciotti,et al. Bioinspired approaches for cancer nanotheranostics. , 2017, Nanomedicine.
[224] Wei Lu,et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[225] R. Flaumenhaft,et al. Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.
[226] Chor Yong Tay,et al. Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.
[227] Francesco Salvatore,et al. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.
[228] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[229] Katharina Gaus,et al. Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. , 2017, Nature nanotechnology.
[230] K. Blennow,et al. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.
[231] Raimo Hartmann,et al. Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.
[232] A. Saleh,et al. Applications of nanoparticle systems in drug delivery technology , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[233] E. Nance,et al. Colloidal stability as a determinant of nanoparticle behavior in the brain. , 2018, Colloids and surfaces. B, Biointerfaces.
[234] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[235] T. Burnouf,et al. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion , 2014, New Biotechnology.
[236] F. Rossi,et al. Direct quantification of nanoparticle surface hydrophobicity , 2018, Communications Chemistry.
[237] F. Caruso,et al. Role of the Protein Corona Derived from Human Plasma in Cellular Interactions between Nanoporous Human Serum Albumin Particles and Endothelial Cells. , 2017, Bioconjugate chemistry.
[238] Wolfgang J Parak,et al. A Decade of the Protein Corona. , 2017, ACS nano.
[239] Hong-ming Ding,et al. Computer simulation of the role of protein corona in cellular delivery of nanoparticles. , 2014, Biomaterials.
[240] M. Basri,et al. Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics , 2018, International journal of nanomedicine.
[241] Beom-Jin Lee,et al. Protein corona: a new approach for nanomedicine design , 2017, International journal of nanomedicine.
[242] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[243] Eran A Barnoy,et al. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. , 2017, Nanomedicine.
[244] Charlotte Lawson,et al. Microvesicles and exosomes: new players in metabolic and cardiovascular disease. , 2016, The Journal of endocrinology.
[245] S. Rapoport. Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications , 2000, Cellular and Molecular Neurobiology.
[246] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[247] Baoquan Ding,et al. Tunable Rigidity of (Polymeric Core)–(Lipid Shell) Nanoparticles for Regulated Cellular Uptake , 2015, Advanced materials.
[248] Han‐Gon Choi,et al. Rabies Virus‐Inspired Silica‐Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors , 2017, Advanced materials.
[249] D. Sen,et al. Immunoglobulins in human aqueous humour. , 1977, The British journal of ophthalmology.
[250] G. Caracciolo,et al. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells. , 2017, Colloids and surfaces. B, Biointerfaces.
[251] K. Landfester,et al. Beyond the protein corona - lipids matter for biological response of nanocarriers. , 2018, Acta biomaterialia.
[252] Katharina Landfester,et al. The Transferability from Animal Models to Humans: Challenges Regarding Aggregation and Protein Corona Formation of Nanoparticles. , 2018, Biomacromolecules.
[253] Ji Hee Kang,et al. Investigation on the effect of nanoparticle size on the blood–brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice , 2018, Journal of drug targeting.
[254] Dirk Strunk,et al. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? , 2016, Biomaterials.
[255] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[256] Tae Geol Lee,et al. Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[257] Yang Yu,et al. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration. , 2018, Journal of biomedical nanotechnology.
[258] S. Mornet,et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.
[259] Morteza Mahmoudi,et al. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.
[260] Jennifer E Gagner,et al. Effect of gold nanoparticle morphology on adsorbed protein structure and function. , 2011, Biomaterials.
[261] S. Alonso,et al. PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization , 2018, International journal of pharmaceutics.
[262] P. Djupesland,et al. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. , 2014, Therapeutic delivery.
[263] C. Taghibiglou,et al. Novel Central Nervous System Drug Delivery Systems , 2014, Chemical biology & drug design.
[264] Baoan Chen,et al. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy , 2017, International journal of nanomedicine.
[265] Chih-Kuang Yeh,et al. Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview , 2014, Theranostics.
[266] Fulvio Magni,et al. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier. , 2018, ACS nano.
[267] Iseult Lynch,et al. Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.
[268] Andrew F. Hill,et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.
[269] Frank A. Witzmann,et al. Silver Nanoparticle Protein Corona Composition in Cell Culture Media , 2013, PloS one.
[270] Samir Mitragotri,et al. Impact of particle elasticity on particle‐based drug delivery systems☆ , 2017, Advanced drug delivery reviews.
[271] Xue-Qing Zhang,et al. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials. , 2018, Small.
[272] J. Rossignol,et al. PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice , 2017, International journal of molecular sciences.
[273] A. Sinclair,et al. Cerebrospinal fluid and lumbar puncture: a practical review , 2012, Journal of Neurology.
[274] Thierry Burnouf,et al. Expansion of adipose tissue mesenchymal stromal progenitors in serum‐free medium supplemented with virally inactivated allogeneic human platelet lysate , 2011, Transfusion.
[275] M Ferrari,et al. Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[276] L. Pereira de Almeida,et al. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[277] Koen Raemdonck,et al. Therapeutic and diagnostic applications of extracellular vesicles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[278] A. Neves,et al. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E , 2016, Journal of Nanobiotechnology.
[279] D. Aarsland,et al. Isoelectric point region pI≈7.4 as a treasure island of abnormal proteoforms in blood , 2016, Discoveries.
[280] S. Savić,et al. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances. , 2017, International journal of pharmaceutics.
[281] A. De Vizcaya-Ruiz,et al. A comparison of the human and mouse protein corona profiles of functionalized SiO2 nanocarriers. , 2017, Nanoscale.
[282] Gert Storm,et al. Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release , 2010, Pharmaceutical Research.
[283] Guixue Wang,et al. Penetration of blood–brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system , 2017, International journal of nanomedicine.
[284] B. Honoré,et al. Proteomic analysis of aqueous humour from patients with acute corneal rejection. , 2005, Acta ophthalmologica Scandinavica.
[285] M. Rubner,et al. Macrophages with cellular backpacks for targeted drug delivery to the brain. , 2017, Biomaterials.
[286] W. Parak,et al. Techniques for the experimental investigation of the protein corona. , 2017, Current opinion in biotechnology.
[287] M. Papi,et al. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. , 2017, Nanoscale.
[288] Ajazuddin,et al. Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[289] R. Tripathi,et al. Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. , 1989, Experimental eye research.
[290] Sara Linse,et al. Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid , 2010, PloS one.
[291] K. Houkin,et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome , 2010, Brain Research.
[292] Samir Mitragotri,et al. Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.
[293] Xiaowei Dong,et al. Current Strategies for Brain Drug Delivery , 2018, Theranostics.
[294] A. Khan,et al. Recent progress of drug nanoformulations targeting to brain , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[295] Samir Mitragotri,et al. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.
[296] F Ornaghi,et al. ApoE‐modified solid lipid nanoparticles: A feasible strategy to cross the blood‐brain barrier , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[297] W. Lam,et al. Protein Corona in Response to Flow: Effect on Protein Concentration and Structure. , 2018, Biophysical journal.
[298] E. Mastrobattista,et al. Drug delivery with living cells. , 2016, Advanced drug delivery reviews.
[299] Jie Zheng,et al. Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.
[300] K. Makino,et al. Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size. , 2018, Bio-medical materials and engineering.
[301] W. Frey,et al. Intranasal delivery of cells to the brain. , 2009, European journal of cell biology.
[302] P. Rameshwar,et al. Stem cell delivery of therapies for brain disorders , 2014, Clinical and Translational Medicine.
[303] Yoshinobu Manome,et al. Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification , 2014, International journal of molecular sciences.
[304] P. Kingshott,et al. The influence of nanostructured materials on biointerfacial interactions. , 2012, Advanced drug delivery reviews.
[305] H. Gendelman,et al. Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.
[306] J. Kreuter. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) , 2013, Journal of microencapsulation.
[307] Kyoungju Choi,et al. Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity , 2017, Nanotoxicology.
[308] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[309] Yu-Wen Wu,et al. Circulatory-cell-mediated nanotherapeutic approaches in disease targeting. , 2017, Drug discovery today.
[310] Beom-Jin Lee,et al. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles , 2017, Journal of Pharmaceutical Investigation.
[311] L. Yang,et al. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells , 2017, International journal of nanomedicine.
[312] P. White,et al. Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. , 2017, ACS nano.
[313] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.